Detalhe da pesquisa
1.
Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
Dis Colon Rectum
; 66(7): 934-945, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834598
2.
Capecitabine maintenance therapy in metastatic colorectal cancer patients with no evidence of disease: CAMCO trial.
Future Oncol
; 19(30): 2045-2054, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37814832
3.
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial.
Oncologist
; 26(1): e90-e98, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33400355
4.
Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.
J Surg Oncol
; 124(8): 1442-1450, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34494280
5.
Application and comparison of different implanted ports in malignant tumor patients.
World J Surg Oncol
; 14(1): 251, 2016 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664131
6.
Efficacy and safety of ripretinib vs. sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2, multicenter, randomized, open-label study in China.
Eur J Cancer
; 196: 113439, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980854
7.
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.
J Clin Oncol
; : JCO2301889, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564700
8.
Effect of Inhibitors on Hydrogen Bond Reduction and Kaolinite Dissolution for Enhanced CO2 Adsorption in Coal.
ACS Omega
; 8(45): 42540-42547, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024748
9.
Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor.
J Gastrointest Oncol
; 14(1): 73-84, 2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915468
10.
Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer.
Cancer Cell
; 41(6): 1152-1169.e7, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172580
11.
mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.
Clin Colorectal Cancer
; 21(1): e12-e20, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963563
12.
Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial.
EClinicalMedicine
; 49: 101480, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747189
13.
mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial.
Ann Transl Med
; 10(4): 171, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280386
14.
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(1): 38-48, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688374
15.
Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies.
Clin Colorectal Cancer
; 20(4): e240-e248, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34334298
16.
Clinical analysis of thymic regrowth following chemotherapy in children and adolescents with malignant lymphoma.
Jpn J Clin Oncol
; 40(12): 1128-34, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20693549
17.
Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
Chin J Cancer
; 29(3): 312-6, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20193116
18.
Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients.
Cancer Manag Res
; 12: 3301-3310, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32494194
19.
Efficacy and Safety of Regorafenib in Combination with Chemotherapy as Second-Line Treatment in Patients with Metastatic Colorectal Cancer: A Network Meta-Analysis and Systematic Literature Review.
Adv Ther
; 37(10): 4233-4248, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32770529
20.
Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair.
Front Oncol
; 10: 579478, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33344234